|
Cyprenil, Selepryl, Deprenyl
|
This product is know as Cyprenil, Selepryl, Deprenyl (L-Deprenyl) |
|
Category:
Antidyskinetic History: Benefits
of the preventive use of Cyprenil Description: Cyprenil (selegiline citrate), contains 300 mg of selegiline
base in Dosage: (1ml = 32 drops)
|
| Cyprenil (Selegiline), is a drug used as an adjunct therapy of Parkinson's disease due to it's anti-neurodegenerative properties it is biochemical defined as a selective monoamine oxidase type B (MAO B) inhibitor, Selegiline was originally developed as an antidepressant agent. To date Selegiline has only been medically approved by regulatory agencies for use on treatment of Parkinson's disease. However recent testing has indicated that Selegiline may have some effect on increasing sexual response in aging animals, an observed retardation of normal age dependent deterioration of renal function and cognitive abilities, including spatial learning ability. |
|
Cyprenil {L-Deprenyl (Selegiline [seh-LEDGE-ah-leen])} works on the brain, not the body whose approved uses are treatment of Alzheimer's & Parkinson's disease. It is also used as a "smart drug" and as such improves motivation, short term memory and to a slight degree aggression. Selegiline seh-LEDGE-ah-leen is used in combination with levodopa or levodopa and carbidopa combination to treat Parkinson's disease, sometimes called shaking palsy or paralysis agitans. This medicine works to increase and extend the effects of levodopa, and may help to slow the progress of Parkinson's disease.
|
|
SELEGILINE AS A SELECTIVE MONOAMINE OXIDASE INHIBITOR Monoamine
oxidase inhibitors became more widely used in the late 1950's, and their
mechanism of action became better understood. Like other enzymes, monoamine
oxidase is a protein that catalyses and regulates the chemical reaction
necessary for the efficient functioning of most of the body's cells. SELEGILINE IN ALZHEIMER'S DISEASE Alzheimer
and Parkinson are both neurodegenerative diseases, several studies have
been conducted to demonstrate the effects of Selegiline on Alzheimer's.
The brain is not composed of discrete components; it is an organ of
interdependent parts. The question arose weather Selegiline, by improving
the tone of the dopaminergic system, might be useful in treating other
neurodegenerative diseases. Selegiline has a unique selectivity to the nigrostriatal dopaminergic neurons, and for the time being is the only promising tool for this purpose in humans because of the following reasons:
|
|
Before you use this medicine... Allergies
- Pregnancy
- Breast-feeding
- Children
- Older
adults - Other
medicines -
Proper
Use of This Medicine Dosing
- For the treatment of Parkinson's disease, the usual dose of selegiline is 5 mg two times a day, taken with breakfast and lunch. Some patients may need less than this. Missed
dose - Storage
-
|
|
Precautions
While Using This Medicine
Any other medicine unless approved or prescribed by your doctor. This especially includes:
Also, for at least 2 weeks after you stop taking this medicine, these foods, beverages, and other medicines may continue to react with selegiline if it was taken in doses higher than those usually used for Parkinson's disease. Check with your doctor or hospital emergency room immediately if severe headache, stiff neck, chest pains, fast heartbeat, or nausea and vomiting occur while you are taking this medicine. These may be symptoms of a serious side effect that should have a doctor's attention. Dizziness, lightheadedness, or fainting may occur, especially when you get up from a lying or sitting position. Getting up slowly may help. If the problem continues or gets worse, check with your doctor. Selegiline may cause dryness of the mouth. For temporary relief, use sugarless candy or gum, melt bits of ice in your mouth, or use a saliva substitute. However, if your mouth continues to feel dry for more than 2 weeks, check with your medical doctor or dentist. Continuing dryness of the mouth may increase the chance of dental disease, including tooth decay, gum disease, and fungus infections. When you start taking selegiline in addition to levodopa or carbidopa and levodopa combination, you may experience an increase in side effects. If this occurs, your doctor may gradually reduce the amount of levodopa or carbidopa and levodopa combination you take. Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention. Stop taking this medicine and get emergency help immediately if any of the following side effects occur:
Check with your doctor as soon as possible if any of the following side effects occur:
Symptoms
of overdose Agitation or irritability
Other side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. However, check with your doctor if any of the following side effects continue or are bothersome:
Less common
or rare Anxiety:
With higher doses, Clenching, gnashing, or grinding teeth or sudden jerky movements of body may occur. Other side effects not listed above may also occur in some patients. If you
notice any other effects, check with your doctor. |
|
A further Note about Dopamine (DA) and Cyprenil (Deprenil [selegiline]) This important neurological transmitter chemical is produced by special DA cells like serotonin cells. We have only a few thousands (30-40) of DA producing brain neurons. DA is broken down by MAO-B specifically. The potent free radicals breakdown intermediate products normally produced are very toxic. In humans dopamine production is gradually reduced in almost a linear fashion throughout life due either to a slow reduction of viable DA producing neurons or to increasing MAO-B activity. When the amount of DA gets small enough in aging the person gets Parkinson disease. This seemingly is what Parkinson's disease is. The amount of dopamine reduction for Parkinson's is around 70-80%. It has been speculated that most people will get Parkinson's if they live long enough. Some speculate that gradual age related reduction of DA production (about 10-13% per decade of adult life) is directly related to long term accumulated free radical damage to the Dopamine cells where it is produced and re-uptaken and then broken down by MAO-B.. The anti-aging
drug (Deprenil or selegiline) has shown so much promise in mice as it
acts by specifically slowing down MAO-B activity. ) Cyprenil (Deprenil/Deprenyl)
has a lot of other benefits but it increases the amount of DA in the brain
to more youthful levels and helps the brain run better. |